6.
Monabati A, Vahedi A, Safaei A, Noori S, Mokhtari M, Vahedi L
. Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma: Is It Different between Over and Under 50 Years of Age?. Asian Pac J Cancer Prev. 2016; 17(4):2285-9.
DOI: 10.7314/apjcp.2016.17.4.2285.
View
7.
Alba-Linero C, Rocha-de-Lossada C, Rachwani-Anil R, Sainz-de-la-Maza M, Sena-Corrales G, Romano V
. Anterior segment involvement in Epstein-Barr virus: a review. Acta Ophthalmol. 2021; 100(5):e1052-e1060.
DOI: 10.1111/aos.15061.
View
8.
Kim H, Ko Y, Kim J, Lee S, Lee H, Park G
. Epstein-Barr Virus-Associated Lymphoproliferative Disorders: Review and Update on 2016 WHO Classification. J Pathol Transl Med. 2017; 51(4):352-358.
PMC: 5525035.
DOI: 10.4132/jptm.2017.03.15.
View
9.
Blauwkamp T, Thair S, Rosen M, Blair L, Lindner M, Vilfan I
. Analytical and clinical validation of a microbial cell-free DNA sequencing test for infectious disease. Nat Microbiol. 2019; 4(4):663-674.
DOI: 10.1038/s41564-018-0349-6.
View
10.
Borroni D, Bonzano C, Sanchez-Gonzalez J, Rachwani-Anil R, Zamorano-Martin F, Pereza-Nieves J
. Shotgun metagenomic sequencing in culture negative microbial keratitis. Eur J Ophthalmol. 2023; 33(4):1589-1595.
DOI: 10.1177/11206721221149077.
View
11.
Gu W, Rauschecker A, Hsu E, Zorn K, Sucu Y, Federman S
. Detection of Neoplasms by Metagenomic Next-Generation Sequencing of Cerebrospinal Fluid. JAMA Neurol. 2021; 78(11):1355-1366.
PMC: 8438621.
DOI: 10.1001/jamaneurol.2021.3088.
View
12.
Chen Y, Yu H, Poon Y, Kuo H
. Ocular post-transplant lymphoproliferative disorder. Taiwan J Ophthalmol. 2017; 5(3):140-142.
PMC: 5602712.
DOI: 10.1016/j.tjo.2014.06.001.
View
13.
Nijland M, Kersten M, Pals S, Bemelman F, Ten Berge I
. Epstein-Barr Virus-Positive Posttransplant Lymphoproliferative Disease After Solid Organ Transplantation: Pathogenesis, Clinical Manifestations, Diagnosis, and Management. Transplant Direct. 2016; 2(1):e48.
PMC: 4946499.
DOI: 10.1097/TXD.0000000000000557.
View
14.
Gu W, Talevich E, Hsu E, Qi Z, Urisman A, Federman S
. Detection of cryptogenic malignancies from metagenomic whole genome sequencing of body fluids. Genome Med. 2021; 13(1):98.
PMC: 8167833.
DOI: 10.1186/s13073-021-00912-z.
View
15.
Llorenc V, Fuster C, Alba-Linero C, Moll-Udina A, Serrano A, Sole M
. Clinical Features of Primary and Systemic Metastatic Intraocular Lymphomas in Spanish Patients. J Ophthalmol. 2019; 2019:6327041.
PMC: 6816004.
DOI: 10.1155/2019/6327041.
View
16.
Takeuchi S, Kawada J, Horiba K, Okuno Y, Okumura T, Suzuki T
. Metagenomic analysis using next-generation sequencing of pathogens in bronchoalveolar lavage fluid from pediatric patients with respiratory failure. Sci Rep. 2019; 9(1):12909.
PMC: 6733840.
DOI: 10.1038/s41598-019-49372-x.
View
17.
Ma L, Jakobiec F, Dryja T
. A Review of Next-Generation Sequencing (NGS): Applications to the Diagnosis of Ocular Infectious Diseases. Semin Ophthalmol. 2019; 34(4):223-231.
DOI: 10.1080/08820538.2019.1620800.
View
18.
Chan C, Rubenstein J, Coupland S, Davis J, Harbour J, Johnston P
. Primary vitreoretinal lymphoma: a report from an International Primary Central Nervous System Lymphoma Collaborative Group symposium. Oncologist. 2011; 16(11):1589-99.
PMC: 3233294.
DOI: 10.1634/theoncologist.2011-0210.
View
19.
Simner P, Miller H, Breitwieser F, Pinilla Monsalve G, Pardo C, Salzberg S
. Development and Optimization of Metagenomic Next-Generation Sequencing Methods for Cerebrospinal Fluid Diagnostics. J Clin Microbiol. 2018; 56(9).
PMC: 6113476.
DOI: 10.1128/JCM.00472-18.
View
20.
Rasche L, Kapp M, Einsele H, Mielke S
. EBV-induced post transplant lymphoproliferative disorders: a persisting challenge in allogeneic hematopoetic SCT. Bone Marrow Transplant. 2013; 49(2):163-7.
DOI: 10.1038/bmt.2013.96.
View